A significant percentage of new pharmaceutical commercialization activities now focus on biological-based therapeutics. This increasing demand for biologicals necessitates the continued expansion and technological improvement of bioprocessing activities. Bioprocessing plays a critical role throughout the entire drug commercialization process…
JUST PUBLISHED: "Standardized and GMP-Ready, Closed-System Processing of Expanded Adipose-Derived Stem Cells Using the Gibco CTS
Rotea System Across 2D and 3D Bioreactor Expansions." Click on the OPEN ACCESS ARTICLES tab below.